Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News3
AZN Share
Chat
AZN Share
Trades5,053
AZN
Live RNS2
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
AZN Company
Research
AZN Company
Timeline5
Share Price Information for Astrazeneca (AZN)
Last checked at -
Last checked at 
Intraday Astrazeneca Share Chart
Astrazeneca News
LONDON BROKER RATINGS: Morgan Stanley cuts BAT; boohoo gets buy rating
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:
LONDON MARKET MIDDAY: Stocks go red but FTSE 100 up on oil exposure
(Alliance News) - Stock prices in London were predominantly lower at midday on Wednesday, though the FTSE 100 continued in the green, thanks to its ex...
TOP NEWS: AstraZeneca and Daiichi hail Enhertu priority review in US
(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Tuesday said their cancer drug Enhertu received a priority review by the Food & Drug Ad...
LONDON MARKET OPEN: FTSE 100 green but other stocks slip ahead of PMIs
(Alliance News) - Stock prices in London opened a mixed bag in London on Tuesday, with the FTSE 100 in the green, but compatriot indices in the red, a...
LONDON BRIEFING: Stocks open in green following UK shop price data
(Alliance News) - Stocks opened higher in London on Tuesday morning, after data showed that UK shop prices have moved further into deflation.
Sensodyne maker Haleon to raise stake in China JV
To buy additional 33% stake for $637 mln *
LONDON MARKET MIDDAY: Stocks stay up as Switzerland cuts rates
(Alliance News) - Stock prices in London were still in the green at midday on Thursday, during a week in which China has been "the talk of the town".
TOP NEWS: AstraZeneca hails Tagrisso approval in US for cancer form
(Alliance News) - AstraZeneca PLC on Thursday said that its cancer drug Tagrisso has been approved in the US for certain type of lung cancer.
Follow the stocks
